Page 9 - புற்றுநோய் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Credit: Ludwig Cancer Research MAY 24, 2021, NEW YORK - A Ludwig Cancer Research study has discovered how to revive a powerful but functionally inert subset of anti-cancer immune cells that are often found within tumors for cancer therapy. Led by Ludwig Lausanne s Ping-Chih Ho and Li Tang of the École Polytechnique Fédérale de Lausanne, the study describes how an immune factor known as interleukin-10 orchestrates the functional revival of terminally exhausted tumor-infiltrating T lymphocytes (TILs), which have so far proved impervious to stimulation by immunotherapies. It also demonstrates that the factor, when applied in combination with cell therapies, can eliminate tumors in mouse models of melanoma and colon cancer. The findings are reported in the current issue of

Chih hoLi tangFondation pierre mercierSwiss institute for experimental cancer researchCancer research instituteTechnology of the people republic chinaA ludwig cancer researchLudwig cancer researchChinese academy of sciencesSwiss national scienceKristian gerhard jebsen foundationBiltema foundationChinese scholarship councilEuropean research councilUniversity of lausanneLudwig institute for cancer research